EP3274689A1 - Method for analysing particles - Google Patents
Method for analysing particlesInfo
- Publication number
- EP3274689A1 EP3274689A1 EP16717422.6A EP16717422A EP3274689A1 EP 3274689 A1 EP3274689 A1 EP 3274689A1 EP 16717422 A EP16717422 A EP 16717422A EP 3274689 A1 EP3274689 A1 EP 3274689A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- sample
- image
- particle
- reconstruction
- photodetector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002245 particle Substances 0.000 title claims abstract description 148
- 238000000034 method Methods 0.000 title claims abstract description 50
- 230000001902 propagating effect Effects 0.000 claims abstract description 3
- 239000011159 matrix material Substances 0.000 claims description 57
- 210000003743 erythrocyte Anatomy 0.000 claims description 34
- 238000001514 detection method Methods 0.000 claims description 32
- 230000006870 function Effects 0.000 claims description 28
- 210000000265 leukocyte Anatomy 0.000 claims description 26
- 210000001772 blood platelet Anatomy 0.000 claims description 17
- 210000004027 cell Anatomy 0.000 claims description 12
- 230000003287 optical effect Effects 0.000 claims description 7
- 210000000601 blood cell Anatomy 0.000 claims description 5
- 230000005855 radiation Effects 0.000 claims description 5
- 230000001427 coherent effect Effects 0.000 claims description 4
- 239000000523 sample Substances 0.000 description 87
- 230000000295 complement effect Effects 0.000 description 25
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 239000013598 vector Substances 0.000 description 14
- 210000001124 body fluid Anatomy 0.000 description 7
- 239000002131 composite material Substances 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 6
- 239000010839 body fluid Substances 0.000 description 6
- 239000011325 microbead Substances 0.000 description 5
- 238000012512 characterization method Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000010355 oscillation Effects 0.000 description 3
- 230000000644 propagated effect Effects 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 238000004820 blood count Methods 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 210000001808 exosome Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000001093 holography Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- QVLTXCYWHPZMCA-UHFFFAOYSA-N po4-po4 Chemical compound OP(O)(O)=O.OP(O)(O)=O QVLTXCYWHPZMCA-UHFFFAOYSA-N 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1429—Signal processing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1429—Signal processing
- G01N15/1433—Signal processing using image recognition
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/41—Refractivity; Phase-affecting properties, e.g. optical path length
- G01N21/45—Refractivity; Phase-affecting properties, e.g. optical path length using interferometric methods; using Schlieren methods
- G01N21/453—Holographic interferometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/4788—Diffraction
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03H—HOLOGRAPHIC PROCESSES OR APPARATUS
- G03H1/00—Holographic processes or apparatus using light, infrared or ultraviolet waves for obtaining holograms or for obtaining an image from them; Details peculiar thereto
- G03H1/04—Processes or apparatus for producing holograms
- G03H1/0443—Digital holography, i.e. recording holograms with digital recording means
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03H—HOLOGRAPHIC PROCESSES OR APPARATUS
- G03H1/00—Holographic processes or apparatus using light, infrared or ultraviolet waves for obtaining holograms or for obtaining an image from them; Details peculiar thereto
- G03H1/04—Processes or apparatus for producing holograms
- G03H1/08—Synthesising holograms, i.e. holograms synthesized from objects or objects from holograms
- G03H1/0866—Digital holographic imaging, i.e. synthesizing holobjects from holograms
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T7/00—Image analysis
- G06T7/0002—Inspection of images, e.g. flaw detection
- G06T7/0012—Biomedical image inspection
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V20/00—Scenes; Scene-specific elements
- G06V20/60—Type of objects
- G06V20/69—Microscopic objects, e.g. biological cells or cellular parts
- G06V20/698—Matching; Classification
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1434—Optical arrangements
- G01N2015/1454—Optical arrangements using phase shift or interference, e.g. for improving contrast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N2015/1488—Methods for deciding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03H—HOLOGRAPHIC PROCESSES OR APPARATUS
- G03H1/00—Holographic processes or apparatus using light, infrared or ultraviolet waves for obtaining holograms or for obtaining an image from them; Details peculiar thereto
- G03H1/04—Processes or apparatus for producing holograms
- G03H1/0443—Digital holography, i.e. recording holograms with digital recording means
- G03H2001/0447—In-line recording arrangement
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03H—HOLOGRAPHIC PROCESSES OR APPARATUS
- G03H1/00—Holographic processes or apparatus using light, infrared or ultraviolet waves for obtaining holograms or for obtaining an image from them; Details peculiar thereto
- G03H1/04—Processes or apparatus for producing holograms
- G03H1/08—Synthesising holograms, i.e. holograms synthesized from objects or objects from holograms
- G03H1/0866—Digital holographic imaging, i.e. synthesizing holobjects from holograms
- G03H2001/0883—Reconstruction aspect, e.g. numerical focusing
Definitions
- the invention is in the field of counting and identifying particles present in a liquid and in particular a body fluid, for example blood.
- Body fluids, particularly blood may comprise particles, for example cells, the number and type of which is useful to know.
- type and blood count, or blood count are commonly performed in laboratory analysis. This type of analysis makes it possible to determine the number and to identify the main constituents of the blood, in particular cells of the red blood cell line, white blood cells, or platelets. These examinations are commonly performed, using powerful automata, but we are looking for simpler, less expensive methods, to obtain comparable performance.
- US2014 / 0327944 also describes a method for classifying particles, for example blood particles, on the basis of holograms, by comparing holograms acquired by an image sensor with a library of simulated holograms. But this process faces the same limits, namely a delicate implementation when the density of the particles is high.
- the method must also have an extended field of view, and must be simple to implement, in particular by avoiding prior particle marking. Furthermore, the method must make it possible to reliably discriminate particles that may be in a body fluid, in particular cells of the red blood cell, white blood cell and platelet lines. In addition, a method is sought that does not require precise knowledge of the distance between the particles and the photodetector.
- the invention addresses this problem by providing a method for identifying a particle present in a sample, for example a sample of a biological fluid, such as blood, the method comprising the following steps:
- determining a profile representing an evolution of said characteristic quantity as a function of said reconstruction distance, along an axis parallel to said axis of propagation and passing through said position;
- a digital reconstruction algorithm By applying a digital reconstruction algorithm is meant the application of a propagation operator to an image, generally in the form of a convolution product.
- the characteristic quantity can be obtained by estimating, at each reconstruction distance, a complex expression of the light wave to which the matrix photodetector is exposed.
- the characteristic quantity can be determined from the module of said complex expression, in which case it is representative of the amplitude of said light wave to which the detector is exposed.
- the characteristic quantity can be determined from the argument of said complex expression, in which case it is representative of the phase of said light wave to which the matrix photodetector is exposed.
- the method comprises:
- a complex reference image the determination of a complex image, referred to as a complex reference image, by applying a digital reconstruction algorithm to the image acquired by the matrix photodetector;
- the process can then comprise:
- the complex reference image may be a complex image formed in a reconstruction plane, distant from the plane of the sample. It can also be a complex image formed in the detection plane.
- the identification can be developed by comparing the evolution of said characteristic quantity with typical profiles determined during a learning phase.
- the position of each particle, in a plane parallel to the plane of the matrix photodetector, can be determined using the image acquired by the photodetector or by means of the complex expression of the light wave to which is exposed the photodetector.
- the light source is preferably a spatially coherent source, and for example a light-emitting diode, in which case a spatial filter is preferably disposed between the light source and the sample.
- the light source may be temporally coherent, for example being a laser diode.
- the matrix photodetector comprises an array of pixels capable of collecting the wave to which the photodetector is exposed.
- the distance between the pixels and the sample may vary between 50 ⁇ and 2 cm, and preferably between 100 ⁇ and 5 mm.
- the sample is not disposed in direct contact with the pixels of the photodetector.
- no magnification optics are disposed between the sample and the matrix photodetector.
- the sample may in particular comprise blood cells.
- the particles can be identified among cell lines of white blood cells, red blood cells or platelets.
- Another object of the invention is a device for identifying a particle, said particle being contained in a sample, the device comprising:
- a light source arranged to produce an incident light wave, along an axis of propagation, towards said sample;
- the matrix photodetector arranged to acquire an image of the sample, the matrix photodetector being able to be exposed to a light wave, resulting from the interference between said incident light wave and a diffraction wave formed by said particle;
- the device comprises a processor, of the electronic computer or microprocessor type, configured to implement the following operations:
- the device has no magnification optics between the matrix photodetector and the analyzed sample.
- the processor may comprise or be connected to a programmable memory, comprising a sequence of instructions for implementing the previously described steps. It can in particular be able to: to determine, at each reconstruction distance, the complex expression of the optical radiation to which the detector is exposed,
- Figure 1 shows the device according to one embodiment of the invention.
- FIG. 2A represents an image acquired by the matrix photodetector.
- FIG. 2B represents the profile of a characteristic quantity, called complementary amplitude, of the light wave to which the photodetector is exposed, as a function of the distance with respect to the photodetector, according to a first example, for different types of particles.
- FIG. 3A represents the profile of a characteristic quantity, called complementary amplitude, of the light wave to which the photodetector is exposed, as a function of the distance relative to the photodetector, for different white blood cells, according to this first example.
- FIG. 3B represents the profile of a characteristic quantity, called complementary amplitude, of the light wave to which the photodetector is exposed, as a function of the distance with respect to the photodetector, for different red blood cells, according to this first example.
- FIG. 4A represents a region of interest of the image acquired by the photodetector, centered on an aggregate of platelets, according to this first example.
- FIG. 4B represents the profile of a characteristic quantity, called complementary amplitude, of the light wave to which the photodetector is exposed, for different plates forming part of the aggregate represented in FIG. 4A.
- FIG. 5A represents the profile of a characteristic quantity, called complementary amplitude, of the light wave to which the photodetector is exposed, as a function of the distance with respect to the photodetector, for different types of particles, according to a second example.
- FIG. 5B represents the profile of the phase of the light wave to which the photodetector is exposed, as a function of the distance z with respect to the photodetector, for different types of particles, according to a second example.
- FIG. 6A represents the profile of a characteristic quantity, called complementary amplitude, of the light wave to which the photodetector is exposed, as a function of the distance with respect to the photodetector, for different types of particles, according to a third example.
- FIG. 6B represents the profile of the phase of the light wave to which the photodetector is exposed, as a function of the distance with respect to the photodetector, for different types of particles, according to a third example.
- FIGS. 7A, 7B and 7C respectively represent the profile of a composite quantity characteristic of the light wave to which the photodetector is exposed, as a function of distance, according to the first, second and third examples.
- FIGS. 8A, 8B, 8C and 8D represent respectively:
- a method for calculating a complex image referred to as a complex reference image, of a sample in a reconstruction plane
- FIG. 8A a representation of an image, called complex reference image, reconstructed after several iterations of the method shown in FIG. 8A.
- FIG. 9A is a hologram acquired by an image sensor, the sample comprising red blood cells dispersed in an aqueous solution.
- FIGS. 9B and 9C respectively represent the module and the phase of a complex image, referred to as a reference image, this complex image being formed in a reconstruction plane.
- FIGS. 9D and 9E are profiles respectively representing an evolution of the modulus and phase of the light wave to which the image sensor is exposed, along an axis of propagation passing through a red cell.
- FIG. 1 represents an exemplary device that is the subject of the invention.
- a light source 11 is able to produce a light wave 12, referred to as an incident light wave, in the direction of a sample 14, along an axis of propagation Z.
- the sample 14 comprises a medium 10, for example a biological fluid, comprising particles 1, 2, 3, 4, 5, .., 9, which it is desired to identify among predetermined types of particles.
- a particle can be a cell.
- a particle may be a red blood cell, a white blood cell or a wafer.
- a particle may also be an organic or inorganic microbead, for example a metal microbead, a polymer or glass microbead, this type of microbead being commonly used in the production of biological protocols.
- a particle may also be a droplet, for example a lipid droplet, immersed in the medium 10. It may also be a microorganism, for example a bacterium or a yeast, or an exosome.
- a particle has a size advantageously less than 1 mm, or even less than 500 ⁇ , and preferably a size between 0.5 ⁇ and 500 ⁇ .
- the term particle refers to both endogenous particles, initially present in the sample examined, and exogenous particles, added to this sample prior to analysis.
- the medium is most frequently a liquid medium, and especially a body fluid, but it can also act agar, or air, or the dry residue of a liquid.
- the method which is the subject of the invention makes it possible to identify each particle observed.
- identification is meant the classification of the particle into a predetermined particle class. It can be a determination of a nature of a particle among predetermined natures, or a determination of a size of a particle among predetermined natures.
- the distance ⁇ between the light source and the sample is preferably greater than 1 cm. It is preferably between 2 and 30 cm.
- the light source, seen by the sample is considered as point. This means that its diameter (or diagonal) is preferably less than one-tenth, better one-hundredth of the distance between the sample and the light source.
- the light arrives at the sample in the form of plane waves, or can be considered as such.
- the light source 11 may be punctual, or be associated with a diaphragm, or spatial filter, not shown in Figure 1, so as to appear punctual.
- the opening of the diaphragm is typically between 5 ⁇ and 1mm, preferably between 50 ⁇ and 500 ⁇ .
- the diaphragm may be replaced by an optical fiber, a first end of which is placed facing a light source, and a second end of which is placed facing the sample.
- said second end can be likened to a point light source 11.
- the sample 14 is delimited by an enclosure having a bottom 15 and a cover 13.
- the side walls of the enclosure are not shown.
- the chamber is a fluid chamber Neubauer C-chip.
- the distance between the bottom 15 and the cover 13 is 100 ⁇ .
- the thickness of the enclosure, along the axis of propagation Z is less than a few cm, for example less than 1 cm, or even less than 1 mm, for example between 50 ⁇ and 500 ⁇ .
- the light source 11 may be temporally coherent but this is not necessary.
- the light source is a laser diode emitting at the wavelength of 450 nm. It is located at a distance of 15 cm from the sample.
- the sample 14 is disposed between the light source 11 and a matrix photodetector, or image sensor, 16. The latter preferably extends parallel to, or substantially parallel to, the bottom 15 of the enclosure delimiting the sample.
- substantially parallel means that the two elements may not be strictly parallel, an angular tolerance of a few degrees, less than 10 ° being allowed.
- the light source is of small spectral width, for example less than 100 nm, or even 20 nm and even more preferably less than 5 nm.
- the term spectral width refers to the half-height width of the emission peak of the light source.
- the photodetector 16 may be a matrix photodetector comprising a matrix of pixels, of the CCD type or a CMOS.
- CMOS are the preferred photodetectors because the size of the pixels is smaller, which makes it possible to acquire images whose spatial resolution is more favorable.
- the detector is a 12-bit APTINA sensor, reference MT9P031. It is a CMOS RGB sensor, whose inter-pixel pitch is 2.2 ⁇ .
- the effective area of the photodetector is 5.7 x 4.3 mm 2 .
- the photodetector extends along a detection plane P, preferably perpendicular to the propagation axis Z of the incident light wave 12.
- the photodetector comprises a matrix of pixels, above which is disposed a transparent protection window.
- the distance between the pixel matrix and the protection window is generally between a few tens of ⁇ at 150 or 200 ⁇ .
- Photodetectors whose inter pixel pitch is less than 3 ⁇ are preferred, in order to improve the spatial resolution of the image.
- the distance d between the particles 1,2, ... 9 and the pixel matrix of the photodetector 16 is, in this example, equal to 1.5 mm. But it can fluctuate depending on the thickness of the fluidic chamber used. In general, and whatever the embodiment, the distance d between a particle and the pixels of the photodetector is preferably between 50 ⁇ and 2 cm, preferably between 100 ⁇ and 2 mm.
- the sample is plasma enriched in white blood cells, obtained according to a usual protocol, after sedimentation of the red blood cells in the presence of Dextran (Sigma Aldrich reference D4876) 6% in Alsever solution, then recovery of the rich plasma white blood cells and in platelets.
- the plasma obtained is then diluted in a PBS buffer at physiological pH (acronym for Phosphate Buffer Saline - Saline Phosphate Buffer). The depletion of red blood cells is not complete and the enriched plasma obtained contains residual red blood cells.
- Particles can be classified into several types of particles, including red blood cells, white blood cells or platelets. Preferably, the particles do not undergo any prior marking.
- FIG. 2A represents an image obtained by the photodetector 16.
- This image represents a global diffraction figure, in which elementary diffraction figures can be distinguished, each elementary diffraction figure being respectively associated with the particles.
- Each elemental diffraction pattern comprises a disk-shaped central area around which concentric, alternately dark and clear rings extend.
- Such an elementary figure allows the selection of a particle to be identified, as well as the determination of the coordinates (x, y) of said particle in the detection plane P, said radial coordinates. These coordinates are for example the center of the elementary diffraction pattern corresponding to said particle.
- Each elementary diffraction pattern is formed by the interference between the incident light wave 12 produced by the source 11, upstream of the sample, and a wave resulting from the diffraction of the incident wave by a particle.
- the photodetector 16 is exposed to a light wave 22 formed by the superposition:
- a processor 20 receives the images of the matrix photodetector 16, and performs a reconstruction of characteristic quantities of the light wave 22 to which the matrix photodetector is exposed, along the axis of propagation Z.
- the microprocessor 20 is connected to a memory 23 able to store instructions for implementing the calculation steps described in this application. It can be connected to a screen 25. The In particular, reconstruction is performed between the matrix photodetector and the observed sample.
- the processor 20 may be able to execute a sequence of instructions stored in a memory, for the implementation of the steps of the identification method.
- the processor may be a microprocessor, or any other electronic computer capable of processing the images provided by the matrix photodetector, to perform one or more steps described in this description.
- the image / acquired by the matrix photodetector shown in FIG. 2A represents the spatial distribution of the intensity I (x, y) of the light wave 22, where x and y designate the coordinates in the plane P of the photodetector. .
- the propagation operator h (x, y, z) has the function of describing the propagation of light between the photodetector 16 and a coordinate point (x, y, z). It is then possible to determine the amplitude u (x, y, z) and the phase ç x, y, z) of this light wave at this distance I z I, called the reconstruction distance, with:
- the application of the propagation operator makes it possible in particular to estimate the complex expression at a distance
- the complex value of the light wave 22 is then reconstructed before the latter reaches the detector. This is called back propagation.
- this backpropagation is implemented by applying a propagation operator h (x, y, -
- the terms upstream and downstream are to be understood according to the direction of propagation of the incident wave 12.
- a mathematical preprocessing is previously applied to the measured intensity I (x, y) before the holographic reconstruction. This improves the quality of results, including reducing artifacts when applying the propagation operator.
- I (x, y) intensity measured by the photodetector at the (x, y) coordinate
- Average (/) mean of the intensity measured in a region of interest of the image /, including said coordinate (x, y). This region of interest may correspond to the entire image formed by the photodetector. This pre-treatment is similar to a normalization of the intensity measured by the intensity of the incident light wave (12), the latter being estimated by the operator Average (/).
- the propagation operator is the Fresnel-Helmholtz function, such that:
- x 'and y' denote the coordinates in the plane of the photodetector
- x and y denote the coordinates in the reconstruction plane, the latter being situated at a distance
- z denotes the coordinate of the image reconstructed along the propagation axis Z of the incident light wave (12).
- the coordinates (x n , y n ), in a plane parallel to the plane of the photodetector 16, of each particle n examined, are determined either by means of the acquired image I (x, y) or from a image û z at a given reconstruction height z.
- FIG. 2B represents, for different types of particles, the evolution of the complementary amplitude û (x n , y n , z), as previously defined, as a function of the distance
- particles 1 to 4 white blood cells designated by the acronym WBC,
- red blood cells designated by the acronym BC
- particles 7 to 9 platelets, designated by the letter PLT.
- reconstruction varies between 1500 ⁇ .
- each particle (1, ..., 9) was observed under a microscope, observation under the microscope serving as a reference measurement, allowing a certain identification.
- the curve û (z) representing the evolution of the complementary amplitude as a function of the reconstruction distance has a minimum less than a threshold of amplitude ⁇ threshoid, followed by a rise towards the baseline BL, this ascent presenting marked oscillations;
- the curve û (z) has a minimum between baseline BL and amplitude threshold ⁇ threshoid, followed by a monotonous rise towards baseline BL;
- the curve û (z) follows the baseline BL and remains confined between two values BL ⁇ ⁇ .
- û (x n , y n ) representing the evolution amplitude complementary to a plurality of reconstruction heights z, and use this profile to perform an identification of the particle between a red blood cell, a white blood cell and a wafer.
- This profile can in particular be compared to a library of profiles made, during a learning phase, on known particles.
- the profile û (z) representing the evolution of the complementary amplitude, along the axis of propagation Z (z coordinate axis) constitutes a signature of the type of the observed particle.
- a complex image of a particle is not formed by carrying out a holographic reconstruction at a predetermined distance from the sample, but a characteristic of the wave 22, resulting from the diffraction of the sample, is reconstructed.
- FIGS. 3A and 3B show complementary amplitude profiles û (z) of the wave 22 to which the detector is exposed, obtained respectively for 50 WBC white cells and 240 RBC red cells. Sufficient repeatability of the profiles is observed to allow a robust classification of the particles on the basis of this profile. These profiles were obtained under experimental conditions similar to those of the preceding example.
- the sample used to make the measurements shown in Figure 3A is an enriched plasma similar to the sample described in connection with Figures 2A and 2B.
- FIG. 3B The sample used to carry out the measurements shown in FIG. 3B comprises whole blood diluted in a phosphate phosphate buffer previously mentioned, dilution factor 1/400.
- FIG. 4B represents complementary amplitude profiles û (z), along the Z axis, obtained for 4 platelets 101, 102, 103, 104, on a sample of enriched plasma type as previously described. Microscopic observation showed that platelets 101, 102, 103 and 104 were aggregated.
- FIG. 4A represents a region of interest of the image I acquired by the photodetector 16. It makes it possible to identify the coordinates (xioi, yioi), (xio2, yio2), (xio3, yio3), (xio4, yio4) of each plate of the aggregate. These profiles were obtained under experimental conditions similar to those of the first example. It is observed that the profile û (z) is similar whether the platelets are aggregated or not, and remains confined around a baseline BL, in a gap BL ⁇ ⁇ . Thus, according to the identification method that is the subject of the invention, the platelets are correctly identified whether they are aggregated or not.
- the distance ⁇ between the light source and the detector is 8 cm.
- the sample is an enriched plasma as previously described.
- a reconstruction of the complex expression U (x, y, z) of the wave 22 has been carried out at a plurality of distances z of the detector, and then at coordinates (x, y) of different particles, the complementary amplitude and the phase of the radiation.
- the nature of the observed particles was confirmed by microscopic observation.
- FIGS. 5A and 5B respectively represent the complementary amplitude û (x, y, z) and the phase ⁇ ( ⁇ , ⁇ , ⁇ ) as a function of the distance z for different particles.
- FIG. 5A it can be seen that:
- the curve û (z) representing the evolution of the complementary amplitude as a function of the reconstruction distance has a marked minimum less than a threshold of amplitude ⁇ threshoid, followed by a ascent towards the base line BL, this ascent presenting marked oscillations;
- the curve û (z) has a minimum between the base line BL and the amplitude threshold ⁇ threshoid, then the curve follows a monotonous rise towards the baseline BL;
- the curve û (z) follows the baseline BL and remains confined between two values BL ⁇ ⁇ .
- the curve ⁇ ( ⁇ ) representing the evolution of the phase ⁇ as a function of the reconstruction distance z has a maximum greater than a first phase threshold c threshoid 1 , then a lower minimum at a second threshoid phase threshold 2 , followed by a rise towards the baseline BL;
- the ⁇ ( ⁇ ) curve has a maximum greater than said first threshoid phase threshold 1 and then a minimum greater than said second threshoid phase threshold 2 , then the curve follows a monotonous rise towards the baseline BL;
- the curve ⁇ ( ⁇ ) representing the evolution of the phase ⁇ as a function of the reconstruction distance remains confined between the two values c threshoid 1 and c threshoid 2 .
- the measured values remain between said first and second phase thresholds.
- the procedure and the sample are similar to the previous example.
- FIGS. 6A and 6B respectively represent the complementary amplitude û (x, y, z) and the phase ⁇ ( ⁇ , ⁇ , ⁇ ) as a function of the distance z for different particles.
- FIG. 6A it can be seen that:
- the curve û (z) representing the evolution of the amplitude u as a function of the reconstruction distance z has a marked minimum less than a threshold of complementary amplitude ⁇ threshoid, followed by a rise towards the baseline BL, this rise having marked oscillations;
- the curve û (z) has a minimum between the base line BL and the amplitude threshold ⁇ threshoid, then the curve follows a monotonous rise towards the baseline BL;
- the curve û (z) follows the baseline BL and remains confined between two values BL ⁇ ⁇
- the curve ⁇ ( ⁇ ) representing the evolution of the phase ⁇ as a function of the reconstruction distance z has a maximum greater than a first phase threshold c threshoid 1 , then a lower minimum at a second threshoid phase threshold 2 , followed by a rise towards the baseline BL;
- the ⁇ ( ⁇ ) curve has a maximum greater than said first threshoid phase threshold 1 and then a minimum greater than said second threshoid phase threshold 2 , then the curve follows a monotonous rise towards the baseline BL;
- the curve ⁇ ( ⁇ ) representing the evolution of the phase ⁇ as a function of the reconstruction distance z remains confined between two values c threshoid 1 , threshoid 2 -The measured values remain between said first and second phase thresholds.
- the sample observed is an enriched plasma as previously described.
- the analyzed particles are three white blood cells (WBC) and one red blood cell (BC). It is observed that, irrespective of the source, the fluctuations of the profile k z) are more important for white blood cells than for red blood cells.
- first composite threshold kthreshoid 1 and a second composite threshold kthreshoid 2 it is possible to determine a first composite threshold kthreshoid 1 and a second composite threshold kthreshoid 2 , such that when the profile kz) remains lower than the first composite threshold kthreshoid 1 and greater than the second composite threshold kthreshoid 2 , the particle analyzed is a red blood cell. When the profile crosses one of these thresholds, the examined particle is identified as a white blood cell.
- the application of a digital propagation operator h to an image / acquired, or hologram, by a matrix photodetector 16 may have certain limits, because the acquired image does not include any information relating to the phase. Also, prior to the profiling, it is preferable to have information relating to the phase of the light wave 22 to which the photodetector 16 is exposed. This information relating to the phase can be obtained by reconstructing an image. complex U z of the sample 14, according to methods described in the prior art, so as to obtain an estimate of the amplitude and the phase of the light wave 22 at the plane P of the matrix photodetector 16 or in a reconstruction plan P z located at a distance ⁇ z ⁇ of the latter. The inventors have developed a method based on the calculation of a complex reference image, described in connection with FIG. 8A. This process comprises the following steps:
- this step is performed by applying the propagation operator h, previously described, to the acquired image / (steps 110 to 170).
- This complex image is referred to as a reference image because it serves as a basis for the formation of the profile on the basis of which the particle is characterized.
- Step 180 Selection of a radial position (x, y) of a particle in the detection plane or in a plane parallel thereto (step 180), either by using the complex reference image U re f or the image / acquired by the photodetector 16.
- this characterization can be performed by comparing the profile obtained with standard profiles obtained during a calibration phase, using standard samples. (step 200).
- Steps 110 to 170 constitute a preferred way of obtaining a reference complex image, noted U re f, this image representing a spatial distribution of the complex expression of the wave 22 in a reconstruction plane P z .
- a reference complex image noted U re f
- this image representing a spatial distribution of the complex expression of the wave 22 in a reconstruction plane P z .
- Step 100 image acquisition
- the image sensor 16 acquires an image / of the sample 14, and more precisely of the light wave 22 transmitted by the latter, to which the image sensor is exposed.
- Such an image, or hologram, is shown in FIG. 8B. This image was made using a sample 14 comprising red blood cells bathed in a saline buffer, the sample being contained in a fluid chamber of thickness 100 ⁇ arranged at a distance d of 1500 ⁇ from a CMOS sensor, according to the previously described device.
- Step 110 Initialization
- This step is an initialization of the iterative algorithm described below. in connection with steps 120 to 180, the exponent k designating the rank of each iteration.
- the image is normalized by a term representative of the intensity of the light wave 12 incident on the sample 14.
- the image UQ _1 obtained in the plane of the sample is propagated in a reconstruction plane P Z , by the application of a propagation operator as previously described, so as to obtain an image complex U Z , representative of the sample 14, in the reconstruction plane P Z.
- the propagation is carried out by convolution of the image UQ _1 by the propagation operator h_ z , so that:
- U k _1 is the complex image in the detection plane P set. day during the previous iteration.
- the reconstruction plane P z is a plane remote from the detection plane P, and preferably parallel to the latter.
- the reconstruction plane P z is a plane P 14 along which the sample 14 extends. Indeed, an image reconstructed in this plane makes it possible to obtain a generally high spatial resolution. It may also be another plane, located a non-zero distance from the detection plane, and preferably parallel to the latter, for example a plane extending between the matrix photodetector 16 and the sample 14.
- Step 130 Calculating an indicator in several pixels
- a quantity e k (x, y) associated with each pixel of a plurality of pixels (x, y) of the complex image U k , and preferably in each of these pixels, is calculated.
- This quantity depends on the value U k (x, y) of the image U k , or of its module, at the pixel (x, y) at which it is calculated. It can also depend on a dimensional derivative of the image in this pixel, for example the module of a dimensional derivative of this image.
- the magnitude s k (x, y) associated with each pixel is a modulus of a difference of the image U k , at each pixel, and the value 1.
- Such a quantity can be obtained according to the expression :
- Step 140 establishing a noise indicator associated with the image U k .
- step 130 we have calculated quantities s k (x, y) in several pixels of the complex image U k . These quantities can form a vector E fe , whose terms are the quantities s k (x, y) associated with each pixel (x, y).
- an indicator said noise indicator, is calculated from a vector standard E fe .
- a norm is associated with an order, so that the norm
- the inventors have indeed considered that the use of a standard of order 1, or of order less than or equal to 1, is particularly suitable. to such a sample, as explained below.
- the magnitude s k (x, y) calculated from the complex image U k , at each pixel (x, y) of the latter, is summed so as to constitute a noise indicator s k associated with the complex image U k .
- s k ⁇ (3 ⁇ 4 y) k (x, y) Due to the use of a standard of order 1, or of order less than or equal to 1, the value of the noise indicator s k decreases when the complex image U k is more and more representative of the sample.
- the algorithm proceeds with a gradual adjustment of the phase (p k (x, y) in the detection plane P, so as to progressively minimize the indicator s k .
- the image U k in the detection plane is representative of the light wave 22 in the detection plane P, both from the point of view of its intensity and of its phase.
- the steps 120 to 160 are aimed at establishing, iteratively, the value of the phase ⁇ p k (x, y) of each pixel of the image U k , minimizing the indicator s k , the latter being obtained on the image U k obtained by propagation of the image U k _1 in the reconstruction plane P z .
- the minimization algorithm may be a gradient descent algorithm or a conjugate gradient descent algorithm, the latter being described below.
- Step 150 Adjust the value of the phase in the detection plane.
- Step 150 aims to determine a value of the phase ⁇ p k (x, y) of each pixel of the complex image U k so as to minimize the indicator s k + 1 resulting from a propagation of the image complex U k in the reconstruction plane P z , during the next iteration k + 1.
- a phase vector ⁇ is established, each term being the phase ⁇ p k (x, y) of a pixel (x, y) of the complex image U k .
- the dimension of this vector is (N P i X , 1), where N P i X denotes the number of pixels considered.
- This vector is updated during each iteration, by the following update expression:
- ⁇ Po (x, y) ⁇ Po -1 (x ⁇ y) + a k p k (x, y) where:
- k is an integer, denoted by the term "step”, and representing a distance
- p k is a vector of direction, of dimension (N P i X , 1), each term of which p (x, y) forms a direction of the gradient Vs k of the indicator s k .
- V k is a gradient vector, of dimension (N P i X , 1), each term of which represents a variation of the indicator s k as a function of each of the degrees of freedom of the unknowns of the problem, i.e. say the terms of the vector ⁇ ⁇ . ;
- PFE-i is an ith t r d e leadership had established in the previous iteration
- ⁇ ⁇ is scale factor applied to the direction vector p fe_ 1 .
- Im represents the imaginary part operator and r 'represents a coordinate (x, y) in the detection plane.
- the scaling factor ⁇ ] ⁇ can be expressed in such a way that:
- the step a k may vary according to the iterations, for example between 0.03 during the first iterations and 0.0005 during the last iterations.
- the updating equation makes it possible to obtain an adjustment of the vector ⁇ , which results in an iterative update of the phase ⁇ (x, y) in each pixel of the complex image UQ.
- This complex image UQ, in the detection plane, is then updated by these new values of the phase associated with each pixel.
- Step 160 Reiteration or algorithm output.
- step 160 consists in repeating the algorithm, by a new iteration of steps 120 to 160, on the basis of the complex image UQ updated during the step 150.
- the convergence criterion can be a predetermined number K of iterations, or a minimal value of the gradient Vs k of the indicator, or a difference considered negligible between two phase vectors ⁇ j "o _ 1 , ⁇ Po consecutive.
- Step 170 Obtain the reference complex image.
- the complex reference image U re f is the complex image UQ resulting from the last iteration in the detection plane P.
- this alternative is however less advantageous because the spatial resolution in the detection plane P is lower than in the reconstruction plane P Z , especially when the reconstruction plane P Z corresponds to a plane P 14 along which the sample 14 extends.
- the spatial resolution of this image allows a good identification of the radial coordinates (x, y) of each particle.
- Step 180 Selection of radial coordinates particle.
- the radial coordinate term designates a coordinate in the detection plane or in the reconstruction plane. It is also conceivable to make this selection from the hologram / 0 or from the complex image U Q obtained in the detection plane following the last iteration.
- FIG. 8C shows the selection of a particle, surrounded by a dashed outline.
- Step 185 Applying a Propagation Operator
- the complex reference image U re f is propagated according to a plurality of reconstruction distances, using a propagation operator h as previously defined, so as to have a plurality of complex images. , say secondary, U re f iZ reconstructed at different distances from the detection plane P or the reconstruction plane P z .
- the values z min and z max are the minimum and maximum coordinates, along the Z axis, according to which the complex reference image is propagated.
- the complex images are reconstructed according to a plurality of coordinates z between the sample 14 and the image sensor 16.
- the complex images can be formed on either side of the sample 14.
- These secondary complex images are established by applying a holographic reconstruction operator h to the reference image U re f.
- the latter is a complex image correctly describing the light wave 22 to which the image sensor is exposed, in particular at its phase, following the iterations of steps 120 to 160. Therefore, the secondary images U re f iZ form a good descriptor of the propagation of the light wave 22 along the axis of propagation Z.
- Step 190 Form a profile During this step, from each secondary complex image U re f iZ , a characteristic quantity, as previously defined, of the light wave 22 is determined so as to determine a profile representing the evolution of said characteristic quantity according to the propagation axis Z.
- the characteristic quantity may be, for example the module or the phase, or their combination.
- FIG. 8D represents the evolution of the phase ⁇ p (z) of the light wave 22 along the axis of propagation Z.
- the particle can then be characterized from the profile formed in the previous step.
- the characterization is then performed by a comparison or classification of the profile formed on the basis of the standard profiles.
- FIGS. 9A-9E Another example is shown in Figures 9A-9E.
- the sample comprises red blood cells diluted in an aqueous solution comprising a buffer PBS (Saline Phosphate Buffer) diluted 1/400.
- the sample 14 was placed in a fluid chamber 15 with a thickness of 100 ⁇ m, placed at a distance of 8 cm from the light-emitting diode previously described, whose spectral band is centered on 450 nm.
- the sample is placed at a distance of 1.5 mm from the previously described CMOS image sensor.
- the opening of the spatial filter 18 is 150 ⁇ .
- Figure 9A shows the image / acquired by the image sensor.
- a red blood cell has been identified, the latter being surrounded by dots on each of these images.
- the radial coordinates (x, y) of this red blood cell have been extracted. From the complex secondary images A re f Z , a profile u (z) representative of the module and a profile ⁇ ( ⁇ ) representative of the phase of the light wave 22 reaching the image sensor 16 have been formed.
- each point of the profile is respectively obtained by determining the module and the phase of a secondary image to said radial coordinates.
- FIGS. 9D and 9E respectively represent the profile of the module and the phase of the red blood cell thus selected.
- the reconstruction plane is located at 1380 ⁇ from the detection plane, which corresponds to the abscissa 76 in FIGS. 9D and 9E.
- the described method is not limited to blood and can be applied to other body fluids, eg urine, cerebrospinal fluid, bone marrow, etc. Moreover, the method can be applied to non-bodily fluids, in particular for the analysis of pollutants or toxins in water or other aqueous solution.
- the method also applies to the detection and identification of particles placed in a non-liquid medium, for example an agar or the dry residue of a body fluid, for example a blood smear resulting in an extensive deposition of dry blood. on a blade.
- a non-liquid medium for example an agar or the dry residue of a body fluid, for example a blood smear resulting in an extensive deposition of dry blood. on a blade.
- the particles are isolated from each other by dry residues or air.
- the particles may be endogenous (for example blood particles) or exogenous (microbeads, droplets).
- endogenous for example blood particles
- exogenous microbeads, droplets
- the examples described above expose simple identification criteria, based on the evolution of the profile of a characteristic quantity as a function of the reconstruction distance, and comparisons using pre-established thresholds. The validity of the criteria is related to the medium in which the particles are placed, as well as to the sample preparation protocol. Other criteria may apply to particles having undergone a different preparation protocol.
- the identification criteria can be defined during a learning phase, carried out on standard samples, comprising known particles.
Landscapes
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Signal Processing (AREA)
- Theoretical Computer Science (AREA)
- Computing Systems (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Quality & Reliability (AREA)
- Multimedia (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1552443A FR3034196B1 (en) | 2015-03-24 | 2015-03-24 | PARTICLE ANALYSIS METHOD |
PCT/FR2016/050643 WO2016151248A1 (en) | 2015-03-24 | 2016-03-23 | Method for analysing particles |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3274689A1 true EP3274689A1 (en) | 2018-01-31 |
EP3274689B1 EP3274689B1 (en) | 2022-02-16 |
Family
ID=53366075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16717422.6A Active EP3274689B1 (en) | 2015-03-24 | 2016-03-23 | Method and apparatsu for analysing particles |
Country Status (7)
Country | Link |
---|---|
US (1) | US10379027B2 (en) |
EP (1) | EP3274689B1 (en) |
JP (1) | JP6727229B2 (en) |
KR (1) | KR102479862B1 (en) |
CN (1) | CN107532989B (en) |
FR (1) | FR3034196B1 (en) |
WO (1) | WO2016151248A1 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3049347B1 (en) * | 2016-03-23 | 2018-04-27 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | METHOD FOR OBSERVING A SAMPLE BY CALCULATING A COMPLEX IMAGE |
FR3049348B1 (en) * | 2016-03-23 | 2023-08-11 | Commissariat Energie Atomique | METHOD FOR CHARACTERIZING A PARTICLE IN A SAMPLE |
WO2017171762A1 (en) * | 2016-03-30 | 2017-10-05 | Siemens Healthcare Diagnostics Inc. | Systems, methods, and apparatus for processing platelet cell data |
DE102016215419A1 (en) * | 2016-08-17 | 2018-02-22 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Measuring arrangement and method for directing and detecting particles |
FR3056749B1 (en) * | 2016-09-28 | 2018-11-23 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | METHOD FOR NUMBERING LEUKOCYTES IN A SAMPLE |
FR3060746B1 (en) * | 2016-12-21 | 2019-05-24 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | METHOD FOR NUMBERING PARTICLES IN AN IMAGING SAMPLE WITHOUT LENS |
FR3063085B1 (en) | 2017-02-17 | 2022-06-17 | Commissariat Energie Atomique | OPTICAL METHOD FOR MONITORING THE IN-VITRO AMPLIFICATION OF A NUCLEOTIDE SEQUENCE |
FR3066503B1 (en) | 2017-05-22 | 2021-05-07 | Commissariat Energie Atomique | MICROORGANISMS ANALYSIS PROCESS |
FR3071609B1 (en) * | 2017-09-27 | 2019-10-04 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | METHOD FOR DETECTING MICROORGANISMS IN A SAMPLE |
FR3073047B1 (en) | 2017-11-02 | 2021-01-29 | Commissariat Energie Atomique | OPTICAL PROCESS FOR ESTIMATING A REPRESENTATIVE VOLUME OF PARTICLES PRESENT IN A SAMPLE |
FR3076617B1 (en) | 2018-01-08 | 2020-02-07 | Horiba Abx Sas | HOLOGRAPHIC IMAGING SYSTEM AND HOLOGRAPHIC IMAGING ANALYSIS METHOD WITH DETECTION OF FAULTS IN THE OBSERVATION CHAMBER |
FR3081997B1 (en) | 2018-05-31 | 2021-04-16 | Commissariat Energie Atomique | DEVICE AND METHOD FOR OBSERVING PARTICLES, IN PARTICULAR SUBMICRONIC PARTICLES |
FR3082944A1 (en) | 2018-06-20 | 2019-12-27 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | METHOD FOR OBSERVING A SAMPLE WITH LENS-FREE IMAGING, TAKING INTO ACCOUNT A SPATIAL DISPERSION IN THE SAMPLE |
FR3082943A1 (en) | 2018-06-20 | 2019-12-27 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | METHOD FOR COUNTING SMALL PARTICLES IN A SAMPLE |
JP2020041928A (en) * | 2018-09-11 | 2020-03-19 | 株式会社東芝 | Self-check system |
FR3086758B1 (en) | 2018-09-28 | 2020-10-02 | Commissariat Energie Atomique | METHOD AND DEVICE FOR OBSERVING A SAMPLE UNDER AMBIENT LIGHT |
FR3087009B1 (en) | 2018-10-09 | 2020-10-09 | Commissariat Energie Atomique | PROCESS FOR DETERMINING PARAMETERS OF A PARTICLE |
EP3839479B1 (en) * | 2019-12-20 | 2024-04-03 | IMEC vzw | A device for detecting particles in air |
FR3118169A1 (en) | 2020-12-22 | 2022-06-24 | Commissariat à l'Energie Atomique et aux Energies Alternatives | Sperm characterization method |
FR3138522A1 (en) | 2022-07-29 | 2024-02-02 | Horiba Abx Sas | Lensless imaging particle detection device |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1692296A (en) * | 2002-09-30 | 2005-11-02 | 独立行政法人科学技术振兴机构 | Cofocal microscope, fluorescence measuring method and polarized light measuring metod using cofocal microscope |
US20080208511A1 (en) * | 2005-03-07 | 2008-08-28 | Michael Trainer | Methods and apparatus for determining characteristics of particles |
ITRM20050120A1 (en) * | 2005-03-16 | 2006-09-17 | Consiglio Nazionale Ricerche | HOLOGRAPHIC METHOD IN NUMERICAL RECONSTRUCTION TO OBTAIN A PICTURE OF A THREE-DIMENSIONAL OBJECT IN WHICH THERE ARE ALSO POINTS OUTSIDE THE DEPTH OF FIELD, AND THE HOLOGRAPHIC APPARATUS USING THIS METHOD. |
SE530750C2 (en) * | 2006-07-19 | 2008-09-02 | Hemocue Ab | A measuring device, a method and a computer program |
GB0701201D0 (en) | 2007-01-22 | 2007-02-28 | Cancer Rec Tech Ltd | Cell mapping and tracking |
CN101842751B (en) * | 2007-10-30 | 2014-10-22 | 纽约大学 | Tracking and characterizing particles with holographic video microscopy |
US8184298B2 (en) * | 2008-05-21 | 2012-05-22 | The Board Of Trustees Of The University Of Illinois | Spatial light interference microscopy and fourier transform light scattering for cell and tissue characterization |
KR20100098107A (en) * | 2009-02-27 | 2010-09-06 | 휴먼전자 주식회사 | A portable cell analyzer and method thereof |
EP3671176B1 (en) * | 2009-10-20 | 2022-04-13 | The Regents of the University of California | Incoherent lensfree cell holography and microscopy on a chip |
US9176152B2 (en) * | 2010-05-25 | 2015-11-03 | Arryx, Inc | Methods and apparatuses for detection of positional freedom of particles in biological and chemical analyses and applications in immunodiagnostics |
US9569664B2 (en) | 2010-10-26 | 2017-02-14 | California Institute Of Technology | Methods for rapid distinction between debris and growing cells |
BR112013010262B1 (en) * | 2010-11-12 | 2022-01-25 | Universite Libre De Bruxelles | Process for characterizing transparent objects in a transparent medium |
WO2012082776A2 (en) | 2010-12-14 | 2012-06-21 | The Regents Of The University Of California | Method and device for holographic opto-fluidic microscopy |
US9605941B2 (en) * | 2011-01-06 | 2017-03-28 | The Regents Of The University Of California | Lens-free tomographic imaging devices and methods |
WO2012112114A1 (en) * | 2011-02-16 | 2012-08-23 | Phase Holographic Imaging Phi Ab | Determination of physical parameters associated with erythrocytes |
CA2842377C (en) * | 2011-07-19 | 2019-08-27 | Ovizio Imaging Systems N.V. | A method and system for detecting and/or classifying cancerous cells in a cell sample |
BR112014013351A2 (en) * | 2011-12-02 | 2017-06-13 | Csir | material analysis system, method and device |
CN102660457A (en) * | 2012-04-17 | 2012-09-12 | 南昌航空大学 | Device and method for analyzing and counting blood cells by lensless holographic diffraction imaging |
EP2667178A3 (en) * | 2012-05-21 | 2018-01-03 | IMEC vzw | Holographic imaging for analyzing molecules |
US9588037B2 (en) | 2012-07-13 | 2017-03-07 | The Regents Of The University Of California | High throughput lens-free three-dimensional tracking of sperm |
FR2993372B1 (en) * | 2012-07-13 | 2015-04-10 | Commissariat Energie Atomique | METHOD AND SYSTEM FOR RECONSTRUCTING OPTICAL PROPERTIES OF DIFFRACTING OBJECTS BATHING IN A LIQUID ENVIRONMENT |
FR3002634B1 (en) * | 2013-02-28 | 2015-04-10 | Commissariat Energie Atomique | METHOD OF OBSERVING AT LEAST ONE OBJECT, SUCH AS A BIOLOGICAL ENTITY, AND ASSOCIATED IMAGING SYSTEM |
WO2015024020A1 (en) * | 2013-08-16 | 2015-02-19 | The General Hospital Corporation | Portable diffraction-based imaging and diagnostic systems and methods |
FR3020682B1 (en) * | 2014-04-30 | 2016-05-27 | Commissariat Energie Atomique | METHOD AND SYSTEM FOR DETECTING AT LEAST ONE PARTICLE IN A BODILY LIQUID, AND ASSOCIATED METHOD FOR DIAGNOSING MENINGITIS |
FR3030749B1 (en) * | 2014-12-19 | 2020-01-03 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | METHOD OF IDENTIFYING BIOLOGICAL PARTICLES BY STACKS OF DEFOCALIZED HOLOGRAPHIC IMAGES |
-
2015
- 2015-03-24 FR FR1552443A patent/FR3034196B1/en not_active Expired - Fee Related
-
2016
- 2016-03-23 CN CN201680022598.1A patent/CN107532989B/en active Active
- 2016-03-23 KR KR1020177030554A patent/KR102479862B1/en active IP Right Grant
- 2016-03-23 WO PCT/FR2016/050643 patent/WO2016151248A1/en active Application Filing
- 2016-03-23 US US15/560,763 patent/US10379027B2/en active Active
- 2016-03-23 EP EP16717422.6A patent/EP3274689B1/en active Active
- 2016-03-23 JP JP2017550232A patent/JP6727229B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
FR3034196A1 (en) | 2016-09-30 |
JP2018514759A (en) | 2018-06-07 |
US10379027B2 (en) | 2019-08-13 |
WO2016151248A1 (en) | 2016-09-29 |
KR102479862B1 (en) | 2022-12-21 |
EP3274689B1 (en) | 2022-02-16 |
US20180080760A1 (en) | 2018-03-22 |
CN107532989B (en) | 2021-08-17 |
JP6727229B2 (en) | 2020-07-22 |
FR3034196B1 (en) | 2019-05-31 |
CN107532989A (en) | 2018-01-02 |
KR20180011762A (en) | 2018-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3274689B1 (en) | Method and apparatsu for analysing particles | |
EP3274694B1 (en) | Method for determining the state of a cell | |
EP3433679B1 (en) | Method for observing a sample, by calculation of a complex image | |
WO2017178723A1 (en) | Holographic method for characterising a particle in a sample | |
EP3559631B1 (en) | Method for counting particles in a sample by means of lensless imaging | |
EP3637194B1 (en) | Method for determining parameters of a particle | |
EP3234550A1 (en) | Method for identifying biological particles using stacks of defocused holographic images | |
EP3241014B1 (en) | System for analysing a transparent sample with control of position, and associated method | |
EP3343201A1 (en) | Method for counting and characterising particles in a moving fluid | |
WO2017207184A1 (en) | Device and method for acquiring a particle present in a sample | |
WO2018060589A1 (en) | Method for counting white blood cells in a sample | |
EP3640743A1 (en) | Method for observing a sample | |
WO2021037935A1 (en) | Method and device for the optical characterisation of particles | |
FR3076618A1 (en) | METHOD AND SYSTEM FOR OPTICALLY INSPECTING A SUBSTRATE | |
EP4232946A1 (en) | Method for classifying a sequence of input images representing a particle in a sample over time | |
WO2019243725A1 (en) | Method and device for counting thrombocytes in a sample | |
WO2020128282A1 (en) | Method for characterising a particle on the basis of a hologram | |
FR3100335A1 (en) | Method and device for optical characterization of particles | |
WO2019135060A1 (en) | Holographic imaging system and holographic imaging analysis method with fault detection in the observation chamber | |
FR3018603A1 (en) | DEVICE FOR ANALYZING AND IMAGING A SURFACE BY DEFLECTOMETRY AND CORRESPONDING METHOD |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20170920 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20180927 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G01N 15/14 20060101AFI20210629BHEP Ipc: G01N 33/49 20060101ALI20210629BHEP Ipc: G03H 1/08 20060101ALI20210629BHEP Ipc: G03H 1/04 20060101ALI20210629BHEP |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20210910 |
|
RAP3 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: HORIBA ABX SAS Owner name: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602016069125 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1469179 Country of ref document: AT Kind code of ref document: T Effective date: 20220315 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: FRENCH |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20220216 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1469179 Country of ref document: AT Kind code of ref document: T Effective date: 20220216 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220216 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220216 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220616 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220516 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220216 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220216 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220216 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220216 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220516 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220216 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220216 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220517 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220216 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220216 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220617 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220216 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220216 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220216 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220216 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220216 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220216 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602016069125 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220216 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220216 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20220331 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20221117 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220323 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220331 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220323 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220331 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220216 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220331 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230517 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220216 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20160323 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220216 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220216 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240321 Year of fee payment: 9 Ref country code: GB Payment date: 20240318 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240320 Year of fee payment: 9 |